These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report. Cairns NJ, Ikonomovic MD, Benzinger T, Storandt M, Fagan AM, Shah AR, Reinwald LT, Carter D, Felton A, Holtzman DM, Mintun MA, Klunk WE, Morris JC. Arch Neurol; 2009 Dec 13; 66(12):1557-62. PubMed ID: 20008664 [Abstract] [Full Text] [Related]
5. Concordance between cerebrospinal fluid biomarkers and [11C]PIB PET in a memory clinic cohort. Zwan M, van Harten A, Ossenkoppele R, Bouwman F, Teunissen C, Adriaanse S, Lammertsma A, Scheltens P, van Berckel B, van der Flier W. J Alzheimers Dis; 2014 Dec 13; 41(3):801-7. PubMed ID: 24705549 [Abstract] [Full Text] [Related]
6. Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels. Babulal GM, Ghoshal N, Head D, Vernon EK, Holtzman DM, Benzinger TLS, Fagan AM, Morris JC, Roe CM. Am J Geriatr Psychiatry; 2016 Nov 13; 24(11):1095-1104. PubMed ID: 27426238 [Abstract] [Full Text] [Related]
9. Exercise and Alzheimer's disease biomarkers in cognitively normal older adults. Liang KY, Mintun MA, Fagan AM, Goate AM, Bugg JM, Holtzman DM, Morris JC, Head D. Ann Neurol; 2010 Sep 13; 68(3):311-8. PubMed ID: 20818789 [Abstract] [Full Text] [Related]
10. Role of family history for Alzheimer biomarker abnormalities in the adult children study. Xiong C, Roe CM, Buckles V, Fagan A, Holtzman D, Balota D, Duchek J, Storandt M, Mintun M, Grant E, Snyder AZ, Head D, Benzinger TL, Mettenburg J, Csernansky J, Morris JC. Arch Neurol; 2011 Oct 13; 68(10):1313-9. PubMed ID: 21987546 [Abstract] [Full Text] [Related]